Condition
Coronary Computed Tomography Angiography clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Coronary Computed Tomography Angiography clinical trials that are recruiting, at sites in 7 countries (most in Italy (2), Hungary (2), China (2)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 7Countries
Newest Coronary Computed Tomography Angiography clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| CCTA-Guided CABG vs CAG-Guided CABG | — | Shanghai | Recruiting | Aug 17, 2026 |
| Intensifying lipid-lowering with evinacumab to reduce coronary plaque in homozygous familial hypercholesterolemia | — | Paris and 12 other locations | Recruiting | Mar 3, 2026 |
| Comparing methods to lower heart rate for cardiac imaging | — | Stockholm, Huddinge | Recruiting | Mar 17, 2025 |
| Comparing heart imaging techniques for coronary artery disease | — | Budapest, Budapest | Recruiting | Nov 1, 2024 |
| Short-term high-dose rosuvastatin effects on coronary plaque using photon-counting CT | — | Budapest, Budapest | Recruiting | Sep 19, 2024 |
| AI tools for predicting high-risk coronary plaques | — | Milan, Milan and 1 other locations | Recruiting | May 13, 2024 |
| Using CCTA to improve management of stable chest pain | — | Beijing, Beijing Municipality and 3 other locations | Recruiting | Dec 31, 2020 |
All recruiting trials (7)
-
CCTA-Guided CABG vs CAG-Guided CABG
This study tests whether planning CABG with a non-invasive CCTA scan works as well as planning with the standard invasive CAG approach for people with blocked heart arteries.
-
Intensifying lipid-lowering with evinacumab to reduce coronary plaque in homozygous familial hypercholesterolemia
This project will test whether adding evinacumab to existing lipid-lowering therapy can shrink or slow coronary plaque buildup in people with homozygous familial hypercholesterolemia using CCTA imaging.
-
Comparing methods to lower heart rate for cardiac imaging
This study is testing different ways to lower heart rate before heart imaging to see which method works best for patients.
-
Comparing heart imaging techniques for coronary artery disease
This study is testing if a new heart imaging method can better identify problems in patients suspected of having coronary artery disease compared to a traditional imaging technique.
-
Short-term high-dose rosuvastatin effects on coronary plaque using photon-counting CT
This trial tests whether a short course of intensified rosuvastatin (40 mg) changes coronary plaque composition and flow on photon‑counting coronary CT in statin‑naive adults with stable chest pain and mild atherosclerosis.
-
AI tools for predicting high-risk coronary plaques
This study is testing a new AI tool to see if it can better predict dangerous plaque buildup in the arteries of people with heart disease.
-
Using CCTA to improve management of stable chest pain
This study is testing if using a special heart scan called CCTA can help doctors better manage stable chest pain and reduce serious heart problems for patients suspected of having blocked arteries.
Related topics
Quick answers
How many Coronary Computed Tomography Angiography clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Italy (2 trials), Hungary (2 trials), China (2 trials), France (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.